NeoGenomics, Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $2.2M | $-17.1M | $-9.9M | $-27.1M | $-45.1M | $-25.9M | $-15.3M | $-17.7M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $8.6M | $8.8M | $8.8M | $8.8M | $9.1M | $9.4M | $9.8M | $9.6M |
| Amortization | $7.6M | $7.6M | $7.6M | $7.6M | $8.1M | $8.4M | $8.4M | $8.4M |
| Stock-Based Compensation | $8.2M | $9.6M | $8.0M | $10.3M | $12.2M | $10.8M | $16.8M | $0 |
| Net Cash from Operating Activities | $20.0M | $-8.1M | $1.3M | $8.9M | $20.3M | $-25.3M | $9.8M | $9.2M |
| Investing Activities | ||||||||
| Capital Expenditures | $8.2M | $5.0M | $7.9M | $8.3M | $6.3M | $4.5M | $11.6M | $10.8M |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-8.3M | $-5.0M | $-6.3M | $-277.0K | $-9.3M | $3.6M | $-5.5M | $-3.5M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $-12.2M | $-338.0K | $431.0K | $765.0K | $-202.4M | $949.0K | $687.0K | $1.2M |
| Net Change in Cash | — | — | — | — | — | — | — | $6.9M |
| Free Cash Flow | $11.7M | $-13.1M | $-6.5M | $570.0K | $14.0M | $-29.8M | $-1.8M | $-1.6M |